XENON PHARMACEUTICALS INC's ticker is and the CUSIP is 98420N905. A total of 4 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,809,510 | +258.9% | 149,000 | +296.3% | 0.00% | – |
| Q1 2024 | $1,618,680 | +197.8% | 37,600 | +218.6% | 0.00% | – |
| Q4 2023 | $543,508 | -72.5% | 11,800 | -79.6% | 0.00% | -100.0% |
| Q3 2023 | $1,977,864 | -8.1% | 57,900 | +3.6% | 0.00% | 0.0% |
| Q2 2023 | $2,152,150 | -7.1% | 55,900 | -13.6% | 0.00% | 0.0% |
| Q1 2023 | $2,315,613 | +662.7% | 64,700 | +740.3% | 0.00% | – |
| Q4 2022 | $303,611 | +21.9% | 7,700 | -6.1% | 0.00% | – |
| Q2 2022 | $249,000 | – | 8,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 100 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |